http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106163514-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
filingDate 2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106163514-B
titleOfInvention Prophylactic and therapeutic agents for attention deficit and hyperactivity disorder
abstract 1-(benzofuran-2-yl)-2-propylaminopentane or its pharmacologically acceptable acid addition salts are known to have been used as antidepressants, psychotropics, Drugs for Alzheimer's disease show excellent effects. However, it is not known that the compound is effective for the prevention and treatment of attention deficit and hyperactivity disorder (ADHD). The present inventors have found that the 1-(benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is effective again for the prevention or treatment of ADHD, as a result , the present invention has been completed.
priorityDate 2013-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189460
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID362572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486030
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21396
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8BW75
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8086
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491223
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21397
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54IT3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450102203
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536174
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID85223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9223
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282471
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID93760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3519
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID85223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420657405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524938
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID214084
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409300699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8003
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10945497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410494780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8016
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9816303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4624
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NSN2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9294
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494386
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID93760
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19643

Total number of triples: 91.